So, Who Benefits From New Cancer Drugs?
THURSDAY, Jan. 16, 2025 (HealthDay News) — Cutting-edge targeted therapies are pushing back the line between life and death for cancer patients. However, these targeted cancer drugs frequently aren’t benefitting members of ethnic and racial minorities in the U.S., a new published in the journal JAMA Oncology says. Nearly halfContinue Reading